Follow The Filings

ADIL Adial Pharmaceuticals

Adial Pharmaceuticals earnings company data as of 7:18 PM ET 8/21

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q2 14 Aug EPS — -11.25 —
Rev — — —

Insider trades

Open-market buys and sales by ADIL's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ADIL insider trades
  • $106K bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Coastlands Capital LP 10% owner
    Buy
    $8,691 3,233 shares at $2.69 +0.8% to stake
    Traded Jul 14–16 Filed Jul 16
  2. Coastlands Capital LP 10% owner
    Buy
    $33K 11,753 shares at $2.78 +3.1% to stake
    Traded Jul 9–10 Filed Jul 13
  3. Coastlands Capital LP 10% owner
    Buy
    $65K 25,000 shares at $2.60 +7.2% to stake
    Traded Jun 29 Filed Jul 1

Also filed in the last 12 months, not counted as buying or selling: 11 stock grants and 3 conversions.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
10-Q QUARTERLY REPORT
8-K 2.02,9.01
8-K 5.02,8.01,9.01
SCHEDULE 13G/A —
8-K 5.02,5.03,5.07,7.01,9.01
10-Q/A AMENDMENT NO. 1 TO FORM 10-Q
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
8-K 8.01
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
8-K 8.01
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
8-K 5.02,5.07,9.01
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
8-K 1.01,8.01,9.01
8-K 3.02
DEF 14A PROXY STATEMENT
8-K 3.01
8-K 2.02,9.01
10-Q QUARTERLY REPORT
8-K 5.02,8.01
8-K/A 9.01
SCHEDULE 13G/A —
SCHEDULE 13G —
8-K 1.01,2.01,2.03,3.02,5.02,5.03,7.01,9.01
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf